Psychemedics Corporation
PMDI
$2.30
$0.062.68%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -11.46% | -9.27% | -14.61% | -8.57% | -12.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -11.46% | -9.27% | -14.61% | -8.57% | -12.36% |
| Cost of Revenue | 3.30% | -13.20% | -8.68% | -11.47% | -14.96% |
| Gross Profit | -32.56% | -2.49% | -24.62% | -3.76% | -8.37% |
| SG&A Expenses | -60.58% | -15.77% | 3.29% | 1.85% | 15.88% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -27.43% | -15.28% | -5.49% | -7.25% | -3.19% |
| Operating Income | 119.35% | 46.25% | -115.59% | -7.39% | -143.82% |
| Income Before Tax | 118.26% | 45.26% | 2.60% | -7.32% | -141.99% |
| Income Tax Expenses | -142.03% | -107.16% | 63.78% | 177.85% | -78.83% |
| Earnings from Continuing Operations | 120.00% | 74.51% | -13.91% | -79.17% | -37.35% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 120.00% | 74.51% | -13.91% | -79.17% | -37.35% |
| EBIT | 119.35% | 46.25% | -115.59% | -7.39% | -143.82% |
| EBITDA | 135.94% | 53.96% | -1,365.96% | -402.04% | -339.64% |
| EPS Basic | 119.41% | 75.10% | -11.88% | -75.56% | -34.10% |
| Normalized Basic EPS | 117.86% | 46.51% | -108.87% | -4.78% | -134.34% |
| EPS Diluted | 117.69% | 75.10% | -11.88% | -75.56% | -34.10% |
| Normalized Diluted EPS | 117.86% | 46.51% | -108.87% | -4.78% | -134.34% |
| Average Basic Shares Outstanding | 3.12% | 2.42% | 1.80% | 2.13% | 2.49% |
| Average Diluted Shares Outstanding | 3.12% | 2.42% | 1.80% | 2.13% | 2.49% |
| Dividend Per Share | -- | -- | -- | -- | -100.00% |
| Payout Ratio | -- | -- | -- | -- | 1.00% |